After participating in this educational activity, attendees should be able to:
1. Recognize spectrum of challenges with Trisomy 13 and 18 neonatal cases.
2. Review real-life cases in context of NICU care and palliative care.
3. Describe prognosis and quality of life issues of infants with Trisomy 13 and 18.


Laura Madore, MD
Assistant Professor of Pediatrics
UMMS - Baystate

Mustafa Caylan, MD
Assistant Professor of Pediatrics
UMMS - Baystate





Faculty Disclosure
Shannon Kay, PH.D., BCBA-D is a stock shareholder in Allergan, Pfizer, Glaxosmithklein, Merck, Gilead.

Session date: 
09/03/2019 - 8:00am to 9:00am EDT
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 APA American Psychological Association
    Baystate Health is approved by the American Psychological Association to sponsor continuing education for psychologists. Baystate Health maintains responsibility for this program and its content.
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.